JP Morgan Chase
TIL icon

JP Morgan Chase’s Instil Bio TIL Stock Holding History

JP Morgan Chase’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,332
Closed -$157K – 7729
2024
Q3 		$157K Buy
+2,332
New +$54.9K ﹤0.01% 5514
2023
Q4 		– Sell
-1,252
Closed -$10.7K – 7867
2023
Q3 		$10.7K Buy
1,252
+1,010
+417% +$10.2K ﹤0.01% 6241
2023
Q2 		$2.67K Sell
242
-25,194
-99% -$308K ﹤0.01% 6295
2023
Q1 		$336K Buy
25,436
+721
+3% +$10.7K ﹤0.01% 4739
2022
Q4 		$312K Sell
24,715
-182
-0.7% -$8.99K ﹤0.01% 4803
2022
Q3 		$2.41M Buy
24,897
+9,068
+57% +$1.04M ﹤0.01% 3325
2022
Q2 		$1.46M Sell
15,829
-126
-0.8% -$17.8K ﹤0.01% 3809
2022
Q1 		$3.43M Buy
15,955
+9,784
+159% +$2.29M ﹤0.01% 3322
2021
Q4 		$2.11M Buy
6,171
+5,647
+1,078% +$2.18M ﹤0.01% 3824
2021
Q3 		$186K Sell
524
-4
-0.8% -$1.49K ﹤0.01% 5279
2021
Q2 		$204K Buy
528
+523
+10,460% +$194K ﹤0.01% 5239
2021
Q1 		$3K Buy
+5
New +$2.57K ﹤0.01% 5915

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Superstring Capital Management New York $140M AUM 323.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase's TIL Position: Q4 2024 in Review

JP Morgan Chase sold out of Instil Bio (TIL) in Q4 2024, closing a stake of 2,332 shares — an estimated $157K sold.

JP Morgan Chase first reported a position in TIL in Q1 2021 and held it in 12 quarters. The position peaked at $3.43M in Q1 2022. 40 funds tracked by Wall St. Rank hold TIL as of Q4 2024.

  • JP Morgan Chase reported no remaining Instil Bio position as of Q4 2024 after selling out during the quarter.
  • JP Morgan Chase sold 2,332 Instil Bio shares in Q4 2024, an estimated $157K.
  • JP Morgan Chase first reported a position in Instil Bio in Q1 2021 and held it in 12 quarters.
  • JP Morgan Chase's Instil Bio position peaked at $3.43M in Q1 2022.
  • 40 funds tracked by Wall St. Rank held Instil Bio as of Q4 2024.

Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.